Breakthroughs in subcutaneous injection drug delivery technology are rapidly being implemented, reshaping the landscape of disease treatment across multiple fields.
Release time:
2025-12-26 16:07
Source:
Recently, several innovative therapies administered via subcutaneous injection have achieved consecutive clinical breakthroughs or received regulatory approval, covering a range of major disease areas including diabetes, hemophilia, and lung cancer. These breakthroughs not only enhance the efficacy and safety of treatment regimens but also significantly improve patient adherence by simplifying the administration process and reducing the frequency of injections, thereby driving profound changes in the treatment paradigms for these diseases.
In the field of diabetes treatment, China’s groundbreaking research on a novel dual-target drug has been published in the prestigious international academic journal Nature. On December 17, Professor Zhu Dalong’s team from Gulou Hospital affiliated with Nanjing University School of Medicine announced that the Phase III clinical trial results for mazdutide—a dual-target agonist targeting both the glucagon receptor (GCGR) and the glucagon-like peptide-1 receptor (GLP-1R)—which was independently developed by their team, have been simultaneously published back-to-back in the journal. It is reported that this marks the first time that Phase III clinical trial results of a Chinese-developed new drug have been featured in Nature.
Previous page
Related News
Exhibition Preview of the 75th China International Medical Equipment Fair (CMEF Spring)
Exhibition Preview for the 75th China International Medical Equipment Fair (CMEF Spring)
Blood lancets are specialized medical devices used for collecting blood samples. They must be operated by professionally trained medical personnel (such as nurses and doctors) in medical institutions (hospitals, clinics, physical examination centers, etc.) in accordance with standardized procedures. Individuals are strictly prohibited from using them on their own, as improper operation may lead to risks such as infection, uncontrollable bleeding, and tissue damage.
Introduction to disposable peripheral blood lancets
Sterility: Strict sterile processing, such as ethylene oxide sterilization or irradiation sterilization, is conducted during the production and packaging process to ensure that it will not cause infection during use.